Diversity in clinical trials is essential to ensure new treatments are effective across all populations. Achieving representation across age, race, ethnicity, socioeconomic status, and geography helps produce more accurate and inclusive results. However, a lack of awareness and limited access often prevents underrepresented groups from participating in studies—posing a risk that new treatments may be less effective for those not included in research data.

That’s why it’s vital to partner with clinical research Plano and partner with clinical research Dallas teams who are committed to inclusion and outreach. These partnerships are key to advancing equity in healthcare innovation.

Achieving Diversity in Clinical Trials in Plano & Dallas

Despite being essential, achieving diversity in clinical studies presents ongoing challenges. Many trials struggle just to meet enrollment goals—Mira Desai, in a National Library of Medicine article, reports that nearly 80% of trials fail to enroll enough patients on time. Understandably, researchers worry that enforcing diversity requirements could add additional obstacles to already difficult recruitment efforts.

Still, it’s more important than ever to partner with clinical research Dallas and partner with clinical research Plano organizations dedicated to overcoming these barriers through outreach and innovation.

Understanding the DEPICT Act

Passed in December 2022, the Diverse and Equitable Participation in Clinical Trials (DEPICT) Act now mandates diversity action plans in clinical research. Under the act, pharmaceutical companies must:

• Report enrollment targets by demographics (age, race, ethnicity).

• Justify the goals with data about disease prevalence in various groups.

• Submit detailed action plans for achieving their targets.

The FDA will provide specific guidelines for these plans, ensuring all trials have a roadmap for inclusivity.

Effective Strategies for Reaching Diverse Communities

Research organizations like AIM Trials are taking multiple approaches to promote diversity, including:

• Technology Expansion: Utilizing telemedicine, wearable devices, and digital biomarkers helps reach remote populations, older adults, and those unable to visit research sites in person.

• Community Engagement: Active outreach through local events, education initiatives, and healthcare partnerships brings studies directly to underserved neighborhoods.

• Targeted Marketing: Though restrictions limit digital targeting based on race or age, traditional media placement and contextual advertising can still reach niche groups effectively.

As industry standards evolve, choosing to partner with clinical research Plano or Dallas-based organizations that are already engaging in these strategies makes a measurable difference.

AIM Trials’ Commitment to Diversity

At AIM Trials, promoting diversity has always been a core value. Long before federal regulations required it, AIM Trials was active in DFW-area communities, working directly with multicultural populations. Our multilingual team—fluent in English, Spanish, Korean, and Hindi—helps break language barriers and encourages wider participation.

Our patient database reflects this commitment to inclusivity:

• 35% Caucasian

• 30% African American

• 15% Asian

• 15% Hispanic

• 1% American Indian

• 4% Other

This diverse participant pool gives AIM Trials a unique advantage when fulfilling demographic goals for clinical studies.

Why Partner with AIM Trials?

AIM Trials stands out as a trusted site for inclusive research. By choosing to partner with clinical research Dallas or Plano-based teams at AIM Trials, you benefit from:

• The ability to complete studies independently without relying on multiple sites.

• Extensive experience in both pediatric and adult trials.

• Proven success recruiting adolescents, a frequently underrepresented group.

• Access to the expansive, varied population of the Dallas–Fort Worth Metroplex.

• Strong capabilities in vaccine trials that require demographic representation.

Your Trusted Partner in Inclusive Research

Whether you’re a sponsor, CRO, or prospective participant, AIM Trials is ready to help. We actively work toward inclusive recruitment and offer the expertise needed to meet today’s diversity standards in research.

To learn more or to partner with clinical research Plano or Dallas-based experts at AIM Trials, contact us today or visit our website to explore current opportunities.